Somatuline Depot reduced the risk of disease progression or death by 53% versus placebo.
At 22 months, more than half of the patients taking Somatuline Depot did not yet have their cancer progress. For those taking placebo, it took 16.6 months until half the patients had their cancer progress.
Learn about the possible side effects of Somatuline Depot
Somatuline Depot is FDA-approved to treat adults with carcinoid syndrome to reduce the need for the use of short-acting somatostatin medicine. It is not known if Somatuline Depot is safe and effective in children.
Somatuline Depot is approved as a deep subcutaneous injection given every 4 weeks by a healthcare provider. Your healthcare provider may change your dose of Somatuline Depot or the length of time between your injections.
Safe’n’Sound® syringe technology. Safe’n’Sound is a registered trademark of NEMERA LA VERPILLIERE SAS.
Not actual size.
Somatuline Depot is given by your healthcare provider as a low-volume, single-use syringe
The medicine reservoir is made up of tightly packed, microscopic nanotubes—which is what allows for the low injection volume of Somatuline Depot.
Somatuline Depot is slowly released into the bloodstream, which is why you’re able to receive it at 1-month intervals.
Somatuline Depot (pronounced So-mat-u-leen Dee-poh) contains lanreotide, a synthetic, or man-made, version of a hormone called somatostatin, which is found naturally in the human body. Natural somatostatin helps to control the release of many different types of hormones.
Although we do not know exactly how Somatuline Depot works, it is believed to interact with certain microscopic structures that exist on the surface of tumor cells.
And we believe that by interacting with these structures, it delays the growth of GEP-NETs that have spread or cannot be removed by surgery, and reduces the need for short-acting somatostatin medicine for the treatment of carcinoid syndrome.
Somatuline Depot may cause serious side effects, including: gallstones, changes to your blood sugar (high or low blood sugar), slow heart rate, and high blood pressure. A conversation on side effects is an important part of talking to your healthcare team about treatment options. These are not all the possible side effects of Somatuline Depot.
The most common side effects of Somatuline Depot in people with:
Somatuline Depot is the 1st and only FDA-approved treatment for adults both to slow the growth of GEP-NETs that have spread or cannot be removed by surgery...and treat carcinoid syndrome to reduce the need for the use of short-acting somatostatin medicine. It is not known if Somatuline Depot is safe and effective in children.